GRC-6211
http://dbpedia.org/resource/GRC-6211 an entity of type: Thing
GRC-6211 is a drug developed by Glenmark Pharmaceuticals which acts as a potent and selective antagonist for the TRPV1 receptor. It has analgesic and antiinflammatory effects and reached Phase IIb human trials, but was ultimately discontinued from development as a medicine, though it continues to have applications in scientific research.
rdf:langString
rdf:langString
GRC-6211
xsd:integer
65310008
xsd:integer
1084243787
xsd:integer
22
xsd:integer
1166398
xsd:integer
81367687
xsd:integer
1
xsd:integer
20
xsd:integer
1
xsd:integer
3
xsd:integer
2
xsd:integer
138393987
rdf:langString
C1CC2C[C@H]NCNC4=CC=CC5=C4C=CN=C5
xsd:integer
1
rdf:langString
JADKHWDNSKIILG-LJQANCHMSA-N
xsd:integer
4
xsd:integer
220
rdf:langString
GRC-6211 is a drug developed by Glenmark Pharmaceuticals which acts as a potent and selective antagonist for the TRPV1 receptor. It has analgesic and antiinflammatory effects and reached Phase IIb human trials, but was ultimately discontinued from development as a medicine, though it continues to have applications in scientific research.
xsd:nonNegativeInteger
2607
xsd:string
1166398-35-1
xsd:string
4S841S9BO9
xsd:string
138393987